You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,004,750

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,004,750 protect, and when does it expire?

Patent 10,004,750 protects FETROJA and is included in one NDA.

This patent has twenty-nine patent family members in twenty-four countries.

Summary for Patent: 10,004,750

Patent landscape, scope, and claims:

Title:	Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof
Abstract:	The present invention provides an acid addition salt or a sodium salt of a compound represented by the formula (IA): ##STR00001## or their hydrate or a stable crystalline solid thereof. The salt or the crystalline solid is extremely useful as an active ingredient for the production of a pharmaceutical product.
Inventor(s):	Matsubara; Fumihiko (Osaka, JP), Kurita; Takanori (Hyogo, JP), Nagamatsu; Daiki (Osaka, JP)
Assignee:	Shionogi & Co., Ltd. (Osaka, JP)
Application Number:	15/508,270
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Process;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 10,004,750

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Shionogi Inc	FETROJA	cefiderocol sulfate tosylate	POWDER;INTRAVENOUS	209445-001	Nov 14, 2019		RX	Yes	Yes	10,004,750	⤷ Subscribe	Y	Y			⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 10,004,750

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2014-179853	Sep 4, 2014

PCT Information
PCT Filed	September 03, 2015	PCT Application Number:	PCT/JP2015/075039
PCT Publication Date:	March 10, 2016	PCT Publication Number:	WO2016/035845

International Family Members for US Patent 10,004,750

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2015312828	⤷ Subscribe
Brazil	112017004166	⤷ Subscribe
Canada	2959295	⤷ Subscribe
China	106795176	⤷ Subscribe
Cyprus	1124838	⤷ Subscribe
Denmark	3190115	⤷ Subscribe
Eurasian Patent Organization	035845	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.